Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

Of the total cases, 177 have been confirmed, and 20 patients are currently on ventilator support, says report.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

There is currently no known cure for neuropathy, and most treatments address acute symptoms with no lasting impact," says Dr.

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more and more cases linking them ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...